Applied Historical Balance Sheet

APLT Stock  USD 1.24  0.03  2.48%   
Trend analysis of Applied Therapeutics balance sheet accounts such as Other Current Liab of 71.3 M, Total Current Liabilities of 74.7 M or Other Liab of 0.0 provides information on Applied Therapeutics' total assets, liabilities, and equity, which is the actual value of Applied Therapeutics to its prevalent stockholders. By breaking down trends over time using Applied Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Applied Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Applied Therapeutics is a good buy for the upcoming year.

Applied Therapeutics Inventory

(259,875)

  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.

About Applied Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Applied Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Applied Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Applied Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Applied currently owns. An asset can also be divided into two categories, current and non-current.

Applied Therapeutics Balance Sheet Chart

At this time, Applied Therapeutics' Non Current Liabilities Total is comparatively stable compared to the past year. Capital Surpluse is likely to gain to about 293.2 M in 2024, despite the fact that Retained Earnings are likely to grow to (445.2 M).

Total Assets

Total assets refers to the total amount of Applied Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Applied Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Applied Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Applied Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents Applied Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Applied Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most accounts from Applied Therapeutics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Applied Therapeutics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.At this time, Applied Therapeutics' Non Current Liabilities Total is comparatively stable compared to the past year. Capital Surpluse is likely to gain to about 293.2 M in 2024, despite the fact that Retained Earnings are likely to grow to (445.2 M).
 2021 2022 2023 2024 (projected)
Other Current Liabilities16.1M27.9M67.9M71.3M
Total Assets89.9M38.4M54.8M56.5M

Applied Therapeutics balance sheet Correlations

0.540.610.750.89-0.94-0.660.520.961.00.49-0.790.860.860.770.560.761.00.7-0.59-0.540.61-0.55-0.48-0.27-0.56
0.540.99-0.140.79-0.73-0.940.050.650.541.0-0.60.850.520.80.99-0.130.54-0.22-0.89-0.97-0.23-0.96-0.97-0.85-0.7
0.610.99-0.060.83-0.77-0.970.20.70.60.99-0.670.890.640.831.0-0.060.61-0.15-0.9-0.98-0.19-0.97-0.97-0.84-0.75
0.75-0.14-0.060.42-0.55-0.030.510.620.76-0.2-0.470.350.570.28-0.121.00.750.990.010.130.910.110.210.35-0.08
0.890.790.830.42-0.88-0.880.380.870.880.75-0.730.980.850.90.810.430.890.35-0.83-0.810.27-0.81-0.76-0.63-0.73
-0.94-0.73-0.77-0.55-0.880.78-0.37-0.99-0.95-0.690.8-0.9-0.75-0.83-0.73-0.55-0.94-0.480.690.7-0.450.70.660.40.61
-0.66-0.94-0.97-0.03-0.880.78-0.3-0.73-0.65-0.940.72-0.94-0.72-0.93-0.96-0.04-0.670.050.980.980.120.990.970.860.87
0.520.050.20.510.38-0.37-0.30.420.480.07-0.60.40.770.390.140.510.520.46-0.28-0.170.22-0.2-0.15-0.02-0.5
0.960.650.70.620.87-0.99-0.730.420.960.61-0.80.870.760.840.660.630.960.56-0.66-0.640.52-0.64-0.58-0.34-0.58
1.00.540.60.760.88-0.95-0.650.480.960.48-0.770.850.830.760.550.761.00.7-0.57-0.530.63-0.54-0.46-0.25-0.53
0.491.00.99-0.20.75-0.69-0.940.070.610.48-0.570.820.510.770.99-0.190.49-0.28-0.88-0.97-0.29-0.96-0.98-0.86-0.7
-0.79-0.6-0.67-0.47-0.730.80.72-0.6-0.8-0.77-0.57-0.79-0.85-0.77-0.61-0.47-0.79-0.370.680.63-0.170.640.60.510.63
0.860.850.890.350.98-0.9-0.940.40.870.850.82-0.790.850.940.860.350.860.27-0.9-0.880.18-0.89-0.84-0.7-0.82
0.860.520.640.570.85-0.75-0.720.770.760.830.51-0.850.850.770.580.570.860.49-0.67-0.590.27-0.61-0.55-0.45-0.69
0.770.80.830.280.9-0.83-0.930.390.840.760.77-0.770.940.770.810.280.770.2-0.95-0.870.12-0.88-0.83-0.73-0.86
0.560.991.0-0.120.81-0.73-0.960.140.660.550.99-0.610.860.580.81-0.110.56-0.2-0.89-0.98-0.23-0.97-0.98-0.84-0.73
0.76-0.13-0.061.00.43-0.55-0.040.510.630.76-0.19-0.470.350.570.28-0.110.760.990.00.120.910.10.20.34-0.09
1.00.540.610.750.89-0.94-0.670.520.961.00.49-0.790.860.860.770.560.760.69-0.59-0.540.61-0.55-0.48-0.27-0.56
0.7-0.22-0.150.990.35-0.480.050.460.560.7-0.28-0.370.270.490.2-0.20.990.690.090.210.940.190.290.43-0.01
-0.59-0.89-0.90.01-0.830.690.98-0.28-0.66-0.57-0.880.68-0.9-0.67-0.95-0.890.0-0.590.090.960.160.970.940.890.91
-0.54-0.97-0.980.13-0.810.70.98-0.17-0.64-0.53-0.970.63-0.88-0.59-0.87-0.980.12-0.540.210.960.251.01.00.90.84
0.61-0.23-0.190.910.27-0.450.120.220.520.63-0.29-0.170.180.270.12-0.230.910.610.940.160.250.230.320.520.07
-0.55-0.96-0.970.11-0.810.70.99-0.2-0.64-0.54-0.960.64-0.89-0.61-0.88-0.970.1-0.550.190.971.00.230.990.90.86
-0.48-0.97-0.970.21-0.760.660.97-0.15-0.58-0.46-0.980.6-0.84-0.55-0.83-0.980.2-0.480.290.941.00.320.990.910.82
-0.27-0.85-0.840.35-0.630.40.86-0.02-0.34-0.25-0.860.51-0.7-0.45-0.73-0.840.34-0.270.430.890.90.520.90.910.71
-0.56-0.7-0.75-0.08-0.730.610.87-0.5-0.58-0.53-0.70.63-0.82-0.69-0.86-0.73-0.09-0.56-0.010.910.840.070.860.820.71
Click cells to compare fundamentals

Applied Therapeutics Account Relationship Matchups

Applied Therapeutics balance sheet Accounts

201920202021202220232024 (projected)
Total Assets48.4M104.5M89.9M38.4M54.8M56.5M
Other Current Liab264K19.8M16.1M27.9M67.9M71.3M
Total Current Liabilities14.1M21.2M26.5M33.4M71.2M74.7M
Total Stockholder Equity32.6M81.9M62.5M4.1M(17.1M)(16.3M)
Net Tangible Assets(19.6M)32.6M81.9M62.5M71.9M75.5M
Net Debt(16.8M)(55.7M)(52.6M)(15.8M)(49.1M)(46.7M)
Retained Earnings(66.8M)(160.7M)(266.3M)(348.8M)(468.6M)(445.2M)
Accounts Payable8.8M640K9.5M4.5M1.7M1.7M
Cash18.9M57.5M53.9M16.7M49.9M34.4M
Non Current Assets Total2.2M1.9M1.5M1.1M447K424.7K
Other Assets199K1.9M200K1.01.151.09
Cash And Short Term Investments38.9M96.8M80.8M30.6M49.9M50.1M
Common Stock Shares Outstanding12.8M22.0M25.6M37.8M84.2M88.5M
Liabilities And Stockholders Equity48.4M104.5M89.9M38.4M54.8M56.5M
Non Current Liabilities Total1.7M1.3M891K878K797K1.4M
Other Current Assets7.3M5.3M7.0M6.5M4.2M5.0M
Other Stockholder Equity51.0M242.8M329.0M352.8M451.4M230.2M
Total Liab15.8M22.6M27.4M34.3M72.0M75.6M
Net Invested Capital32.6M83.0M63.3M5.1M(16.8M)(16.0M)
Total Current Assets46.2M102.6M88.4M37.3M54.4M55.4M
Accumulated Other Comprehensive Income(2K)(112K)(107K)51K45.9K48.2K
Net Working Capital32.1M81.4M61.9M3.9M(16.8M)(16.0M)
Short Term Debt356K812K884K954K858K607.2K
Common Stock1K2K3K5K8K8.4K
Capital Stock1K2K3K5K8K8.4K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Applied Stock Analysis

When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.